Prenatal detection of congenital heart disease in a low risk population undergoing first and second trimester screening

Prenatal Diagnosis

Volumn 35, Issue 4, 2015, Pages 325-330

  Jørgensen, Ditte E S ^a   Vejlstrup, Niels ^a   Jørgensen, Connie ^a   Maroun, Lisa Leth ^a   Steensberg, Jesper ^a   Hessellund, Anette ^b   Jørgensen, Finn Stener ^c,g   Larsen, Torben ^d   Shalmi, Anne Cathrine ^e   Skibsted, Lillian ^f,g   Zingenberg, Helle ^h   Ekelund, Charlotte ^a   Tabor, Ann ^a,g  

^a Rigshospitalet   (Denmark)

^b NAESTVED HOSPITAL   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d HOLBÆK HOSPITAL   (Denmark)

^e HILLERØD HOSPITAL   (Denmark)

^f ROSKILDE HOSPITAL   (Denmark)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

^h GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESSORY SPLEEN; AORTA COARCTATION; ARTERIAL TRUNK; ARTICLE; ASPLENIA; ATRIOVENTRICULAR SEPTAL DEFECT; AUTOPSY; COMPLETE TRANSPOSITION OF THE GREAT ARTERY; CONGENITAL HEART DISEASE; CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERY; DENMARK; FALLOT TETRALOGY; FETUS; FETUS ECHOGRAPHY; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; GREAT VESSELS TRANSPOSITION; HEART RIGHT VENTRICLE DOUBLE OUTLET; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; HYPOPLASTIC RIGHT HEART SYNDROME; INFANT; LOW RISK POPULATION; MAJOR CLINICAL STUDY; NUCHAL TRANSLUCENCY MEASUREMENT; POSTNATAL CARE; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; CONGENITAL HEART MALFORMATION; ECHOGRAPHY; FEMALE; FETUS HEART; HIGH RISK PREGNANCY; NEWBORN; PREGNANCY; PROCEDURES; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

AUTOPSY; DENMARK; FEMALE; FETAL HEART; FETUS; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY, HIGH-RISK; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL;

EID: 84926254690     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4525     Document Type: Article

References (33)

1. Karsdorp PA, Everaerd W, Kindt M, Mulder BJ. Psychological and cognitive functioning in children and adolescents with congenital heart disease: a meta-analysis. J Pediatr Psychol 2007;32(5):527-41.
2. Makrydimas G, Sotiriadis A, Ioannidis JP. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. Am J Obstet Gynecol 2003;189(5):1330-5.
3. Zomer AC, Vaartjes I, Grobbee DE, Mulder BJ. Adult congenital heart disease: new challenges. Int J Cardiol 2013;163(2):105-7.
4. Crane JP, LeFevre ML, Winborn RC, et al. A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses. The RADIUS Study Group. Am J Obstet Gynecol 1994;171(2):392-9.
5. Grandjean H, Larroque D, Levi S. The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study. Am J Obstet Gynecol 1999;181(2):446-54.
6. Pinto NM, Keenan HT, Minich LL, et al. Barriers to prenatal detection of congenital heart disease: a population-based study. Ultrasound Obstet Gynecol 2012;40(4):418-25.
7. Stefos T, Plachouras N, Sotiriadis A, et al. Routine obstetrical ultrasound at 18-22weeks: our experience on 7, 236 fetuses. J Matern Fetal Med 1999;8(2):64-9.
8. Tegnander E, Eik-Nes SH. The examiner's ultrasound experience has a significant impact on the detection rate of congenital heart defects at the second-trimester fetal examination. Ultrasound Obstet Gynecol 2006;28(1):8-14.
9. Tegnander E, Williams W, Johansen OJ, et al. Prenatal detection of heart defects in a non-selected population of 30, 149 fetuses - detection rates and outcome. Ultrasound Obstet Gynecol 2006;27(3):252-65.
10. Vial Y, Tran C, Addor MC, Hohlfeld P. Screening for foetal malformations: performance of routine ultrasonography in the population of the Swiss Canton of Vaud. Swiss Med Wkly 2001;131(33-34):490-4.
11. Bonnet D, Coltri A, Butera G, et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999;99(7):916-18.
12. Tworetzky W, McElhinney DB, Reddy VM, et al. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 2001;103(9):1269-73.
13. Ekelund CK, Jorgensen FS, Petersen OB, et al. Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study. BMJ 2008;337:a2547.
14. Ekelund CK, Andersen HJ, Christensen J, et al. Down's syndrome risk assessment in Denmark - secondary publication. Ugeskr Laeger 2010;172(23):1759-61.
15. ISOUG Education Committee. Cardiac screening examination of the fetus: guidelines for performing the 'basic' and 'extended basic' cardiac scan. Ultrasound Obstet Gynecol 200627(1):107-13.
16. Souka AP, Von Kaisenberg CS, Hyett JA, et al. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005;192(4):1005-21.
17. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011;39(7 Suppl):30-3.
18. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull 1998;45(3):320-3.
19. Ekelund CK, Skovbo P, Holmskov A, et al. Development and establishment of a national Danish fetal medicine database for quality surveillance and research. 2014 [WWW document]. URL http://onlinelibrary.wiley.com/doi/10.1002/uog.7151/full [accessed on 5 april 2014]
20. Hauerberg L, Skibsted L, Graem N, Maroun LL. Correlation between prenatal diagnosis by ultrasound and fetal autopsy findings in second-trimester abortions. Acta Obstet Gynecol Scand 2012;91(3):386-90.
21. Khoo NS, Van EP, Richardson M, Robertson T. Effectiveness of prenatal diagnosis of congenital heart defects in South Australia: a population analysis 1999-2003. Aust N Z J Obstet Gynaecol 2008;48(6):559-63.
22. Mogra R, Alabbad N, Hyett J. Increased nuchal translucency and congenital heart disease. Early Hum Dev 2012;88(5):261-7.
23. Clur SA, Ottenkamp J, Bilardo CM. The nuchal translucency and the fetal heart: a literature review. Prenat Diagn 2009;29(8):739-48.
24. Muller MA, Clur SA, Timmerman E, Bilardo CM. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies. Prenat Diagn 2007;27(2):164-9.
25. Simpson LL, Malone FD, Bianchi DW, et al. Nuchal translucency and the risk of congenital heart disease. Obstet Gynecol 2007;109(2 Pt 1):376-83.
26. Westin M, Saltvedt S, Bergman G, et al. Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16, 383 fetuses. Ultrasound Obstet Gynecol 2006;27(6):632-9.
27. Hafner E, Schuller T, Metzenbauer M, et al. Increased nuchal translucency and congenital heart defects in a low-risk population. Prenat Diagn 2003;23(12):985-9.
28. Hyett J, Perdu M, Sharland G, et al. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14weeks of gestation: population based cohort study. BMJ 19999;318(7176):81-5.
29. Mavrides E, Cobian-Sanchez F, Tekay A, et al. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001;17(2):106-10.
30. Syngelaki A, Chelemen T, Dagklis T, et al. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13weeks. Prenat Diagn 2011;31(1):90-102.
31. Chelemen T, Syngelaki A, Maiz N, et al. Contribution of ductus venosus Doppler in first-trimester screening for major cardiac defects. Fetal Diagn Ther 2011;29(2):127-34.
32. Pereira S, Ganapathy R, Syngelaki A, et al. Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects. Obstet Gynecol 2011;117(6):1384-91.
33. Klemmensen AK, Olsen SF, Osterdal ML, Tabor A. Validity of preeclampsia-related diagnoses recorded in a national hospital registry and in a postpartum interview of the women. Am J Epidemiol 2007;166(2):117-24.